HomeComparePWCO vs MRK

PWCO vs MRK: Dividend Comparison 2026

PWCO yields 21276.60% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PWCO wins by $97010612475345666048.00M in total portfolio value
10 years
PWCO
PWCO
● Live price
21276.60%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$97010612475345666048.00M
Annual income
$96,121,906,681,138,280,000,000,000.00
Full PWCO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PWCO vs MRK

📍 PWCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPWCOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PWCO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PWCO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PWCO
Annual income on $10K today (after 15% tax)
$1,808,510.64/yr
After 10yr DRIP, annual income (after tax)
$81,703,620,678,967,540,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PWCO beats the other by $81,703,620,678,967,540,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PWCO + MRK for your $10,000?

PWCO: 50%MRK: 50%
100% MRK50/50100% PWCO
Portfolio after 10yr
$48505306237672833024.00M
Annual income
$48,060,953,340,569,140,000,000,000.00/yr
Blended yield
99.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PWCO
No analyst data
Altman Z
-26.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PWCO buys
0
MRK buys
0
No recent congressional trades found for PWCO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPWCOMRK
Forward yield21276.60%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$97010612475345666048.00M$56.8K
Annual income after 10y$96,121,906,681,138,280,000,000,000.00$9,798.13
Total dividends collected$96952003851437047808.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PWCO vs MRK ($10,000, DRIP)

YearPWCO PortfolioPWCO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,138,360$2,127,659.57$11,206$366.19+$2.13MPWCO
2$427,493,766$425,205,721.71$12,650$502.35+$427.48MPWCO
3$79,902,016,567$79,444,598,237.21$14,407$694.19+$79902.00MPWCO
4$13,962,909,303,089$13,877,414,145,361.49$16,585$967.82+$13962909.29MPWCO
5$2,281,373,643,503,257$2,266,433,330,548,952.50$19,342$1,363.89+$2281373643.48MPWCO
6$348,523,597,044,532,160$346,082,527,245,983,700.00$22,913$1,947.19+$348523597044.51MPWCO
7$49,784,832,739,727,780,000$49,411,912,490,890,130,000.00$27,662$2,823.89+$49784832739727.75MPWCO
8$6,649,757,374,953,423,000,000$6,596,487,603,921,915,000,000.00$34,159$4,173.35+$6649757374953423.00MPWCO
9$830,566,162,810,647,000,000,000$823,450,922,419,446,800,000,000.00$43,337$6,308.80+$830566162810647040.00MPWCO
10$97,010,612,475,345,670,000,000,000$96,121,906,681,138,280,000,000,000.00$56,776$9,798.13+$97010612475345666048.00MPWCO

PWCO vs MRK: Complete Analysis 2026

PWCOStock

PwrCor, Inc. provides energy infrastructure and alternative energy solutions in the United States. The company manages infrastructure projects for commercial and institutional customers. Its projects include a combination of energy infrastructure components, including electrical power generation, steam production, or chilled water production projects, as well as the infrastructure to distribute these services. The company also commercializes engine technology that converts low-grade heat to mechanical energy for power generation. It serves domestic non-profit institutions and organizations; the waste-heat-to-energy and geothermal marketplace; and the independent power producer market. The company was formerly known as Receivable Acquisition & Management Corporation and changed its name to PwrCor, Inc. in March 2017. PwrCor, Inc. is headquartered in New York, New York.

Full PWCO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PWCO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PWCO vs SCHDPWCO vs JEPIPWCO vs OPWCO vs KOPWCO vs MAINPWCO vs JNJPWCO vs ABBVPWCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.